overcoming resistance to egfr inhibitors in egfr mutant nsclc online kopen

Ben je op zoek naar overcoming resistance to egfr inhibitors in egfr mutant nsclc? Bekijk onze boeken selectie en zie direct bij welke webshop je overcoming resistance to egfr inhibitors in egfr mutant nsclc online kan kopen. Ga je voor een ebook of paperback van overcoming resistance to egfr inhibitors in egfr mutant nsclc. Zoek ook naar accesoires voor overcoming resistance to egfr inhibitors in egfr mutant nsclc. Zo ben je er helemaal klaar voor. Ontdek ook andere producten en koop vandaag nog je overcoming resistance to egfr inhibitors in egfr mutant nsclc met korting of in de aanbieding. Alles voor veel leesplezier!

Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC

Overcoming Resistance to EGFR Inhibitors in EGFR Mutant NSCLC presents updated information on how EGFR mutant lung cancers evolve to;

Vergelijkbare producten zoals Overcoming Resistance to EGFR Inhibitors in EGFR-Mutant NSCLC

Third Generation EGFR Inhibitors

Third Generation EGFR Inhibitors: Overcoming EGFR Resistance and Toxicity Problems reviews current issues relating to the design;

Vergelijkbare producten zoals Third Generation EGFR Inhibitors

Fighting Lung Cancer Through the HER Family of Surface Receptors

chemotherapy for advanced NSCLC does not provide a great long-term benefit in terms of survival. Accordingly, a different therapeutic approach has to;

Vergelijkbare producten zoals Fighting Lung Cancer Through the HER Family of Surface Receptors

Lung Cancer, An Issue of Hematology/Oncology Clinics

; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many;

Vergelijkbare producten zoals Lung Cancer, An Issue of Hematology/Oncology Clinics

Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies

Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies presents a description of the sensitizers used to overcome resistance to anti;

Vergelijkbare producten zoals Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies

Iressa-A Boon to Colon Cancer

binding in EGFR kinase. The consequences help to understand the nature of epidermal growth factor receptor kinase and how to inhibit intra and;

Vergelijkbare producten zoals Iressa-A Boon to Colon Cancer

New Skin Toxicities for New Anticancer Therapies

unresponsive neoplasms of the colon, pancreas, lung, (NSCLC), breast, head and neck and melanoma. This book aims to emphasize skin toxicity associated;

Vergelijkbare producten zoals New Skin Toxicities for New Anticancer Therapies

Advances in Systemic Therapy for Non-Small Cell Lung Cancer, An Issue of Thoracic Surgery Clinics

Big 3; Advances in Systemic Therapy; Liquid Biopsies in NSCLC; Combining Immunotherapy and Chemotherapy for NSCLC; ROS-1 Mutations; EGFR;

Vergelijkbare producten zoals Advances in Systemic Therapy for Non-Small Cell Lung Cancer, An Issue of Thoracic Surgery Clinics

Targeted Therapies in Lung Cancer

management of patients with non-small cell lung cancer (NSCLC). It will educate nurses and practitioners about the scope of therapy to assure safe;

Vergelijkbare producten zoals Targeted Therapies in Lung Cancer

Proteinkinase Inhibitors

cover the function, structure and topology of Proteinkinases, molecular modelling, disclose how to achieve high level of selectivity for kinase;

Vergelijkbare producten zoals Proteinkinase Inhibitors

Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy

Series, focuses on strategic combination therapies that involve a variety of tyrosine kinase inhibitors working together to overcome multi-drug;

Vergelijkbare producten zoals Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy

The role of EGFR in c-fos-dependent osteosarcoma formation

Vergelijkbare producten zoals The role of EGFR in c-fos-dependent osteosarcoma formation

Resistance to Targeted Therapies in Breast Cancer

We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those;

Vergelijkbare producten zoals Resistance to Targeted Therapies in Breast Cancer

Cardio-oncology Related to Heart Failure, An Issue of Heart Failure Clinics

potential cause of Heart Failure; EGFR target based therapy; Amyloidosis; How to manage Heart Failure in a patient with cancer; Advanced HF/Txp;

Vergelijkbare producten zoals Cardio-oncology Related to Heart Failure, An Issue of Heart Failure Clinics

Lung Cancer Therapy Annual 7

Highly Commended, BMA Medical Book Awards 2013 Oncology research and practice in lung cancer continues to develop rapidly. This latest;

Vergelijkbare producten zoals Lung Cancer Therapy Annual 7

Infections Related to Biologics An Issue of Infectious Disease Clinics of North America

, hematologic malignancies, solid tumors, and other conditions; there is a lack of guidance in the literature on how to address their infectious risks;

Vergelijkbare producten zoals Infections Related to Biologics An Issue of Infectious Disease Clinics of North America

Epigenetic Regulation in Overcoming Chemoresistance

of biomedical field who are interested in learning about epigenetic regulation methods to reverse chemo-resistance in cancers. Presents;

Vergelijkbare producten zoals Epigenetic Regulation in Overcoming Chemoresistance

Resistance to Aromatase Inhibitors in Breast Cancer

regulation of aromatase genes, and structure and function of aromatase protein. The second section provides the detailed mechanisms of resistance to;

Vergelijkbare producten zoals Resistance to Aromatase Inhibitors in Breast Cancer

Lung Cancer and Personalized Medicine

This, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung;

Vergelijkbare producten zoals Lung Cancer and Personalized Medicine

Resistance to Targeted Therapies in Multiple Myeloma

Multiple Myeloma remains an incurable malignancy. As the disease progresses, it invariably becomes resistant to treatment and almost all;

Vergelijkbare producten zoals Resistance to Targeted Therapies in Multiple Myeloma

Resistance to Tyrosine Kinase Inhibitors

to the most commonly used classes of tyrosine kinase inhibitors, and will focus specific chapters on resistance to BCR-ABL1, FLT3;

Vergelijkbare producten zoals Resistance to Tyrosine Kinase Inhibitors

Nimotuzumab en el tratamiento de tumores de esofago de origen

factor de crecimiento epidermico (EGFR) humano. La eficacia clinica se ha demostrado en tumores de cabeza y cuello y gliomas de lato grado;

Vergelijkbare producten zoals Nimotuzumab en el tratamiento de tumores de esofago de origen

The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America

of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase;

Vergelijkbare producten zoals The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America

Lung Cancer, An Issue of Surgical Oncology Clinics of North America

This issue of Surgical Oncology Clinics of North America, guest edited by Dr. Mark Krasna, is devoted to Lung Cancer. Dr. Krasna has;

Vergelijkbare producten zoals Lung Cancer, An Issue of Surgical Oncology Clinics of North America

The use of 18FDG PET in NSCLC

The use of 18FDG PET in NSCLC;

Vergelijkbare producten zoals The use of 18FDG PET in NSCLC

Lung Cancer

discussed in this issue include but are not limited to: Lung Cancer TNM Staging: The 8th Edition; New Surgical Approaches in the Treatment of NSCLC;

Vergelijkbare producten zoals Lung Cancer

Head and Neck Cancer, An Issue of Hematology/Oncology Clinics of North America

This issue of Hematology/Oncology Clinics of North America is devoted to Head and Neck Cancer. Guest Editor Alexander Colevas, MD has;

Vergelijkbare producten zoals Head and Neck Cancer, An Issue of Hematology/Oncology Clinics of North America